aetherAI   aetherAI is Asia's leading medical image AI company with a special focus in digital pathology. Dedicated to elevating the standard of pathological diagnosis and improve the quality of care, aetherAI strives to provide solutions for digital pathology transformation and AI-powered diagnostic support.



Aiforia equips pathologists and scientists in preclinical, academic, and clinical labs with the most powerful cloud-based technology to increase the speed, accuracy and consistency of analyzing large and complex medical images across a variety of fields from oncology to neuroscience. Aiforia is composed of an ideal mix of scientists experienced in a variety of medical areas from pathology to cancer diagnostics, software developers who collectively hold over 100 years’ experience in artificial intelligence, and a business team with backgrounds in the pharmaceutical and biotechnology industries.



Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedInTwitterYouTubeFacebook, and Instagram.



Corista delivers the industry’s most extensive array of workflow, analytical and collaborative tools for pathology. Medical centers can seamlessly integrate their LIS/EHRs in a unified digital environment of whole-slide and gross pathology images. Physicians have 21st-century tools to collaborate, communicate, teach, and report with access to ‘best-of-breed’ image analytics. Specialists can receive digital consults from across the globe. Scientists have an R&D platform to develop and apply their algorithms. Corista provides a new level of interoperability for pathology, integrating whole slide image scanning systems, image analytics, and LIS/EHR platforms in a rich collaborative environment. Corista: This is Integrated Pathology™.



At Fluidigm, we empower our customers to reveal meaningful insights in health and disease, identify actionable markers to inform life decisions and accelerate the development of more effective therapies. Fluidigm develops, manufactures, and markets research products for life science analytical and preparatory systems for use in mass cytometry, high-throughput genomics, and single cell genomics applications. Experiments performed on the Hyperion™ Imaging System deliver unprecedented insight into the tissue microenvironment with single cell resolution. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide.



Hamamatsu Corporation is the North American subsidiary of Hamamatsu Photonics K.K. (Japan). We manufacture detectors, light sources, cameras, and systems including the NanoZoomer instruments for whole slide scanning in both brightfield and fluorescence applications. The NanoZoomer converts glass slides into digital images quickly and accurately, making it perfect for viewing and analyzing the slides. Our instruments deliver reliable scanning and image quality you’ve come to expect from Hamamatsu.



An innovative medical technology company primarily focused on improving women’s health and well-being, Hologic enables healthier lives everywhere, every day, with clinical superiority that delivers life-changing diagnostic, detection, surgical and medical aesthetic products rooted in science and driven by technology. Hologic: The Science of Sure in action.



Huron Digital Pathology - We are on a mission to transform glass biopsy slides into shareable knowledge. Our Scan, Index, and Search solution for pathology combines award-winning whole slide imaging hardware with powerful image search technology to connect pathologists, researchers and educators with the expertise of their colleagues to help speed up diagnosis and accelerate disease research.



INFINITT North America is an award-winning provider of medical image and data management solutions for healthcare. Our cutting-edge technologies support radiology, cardiology, oncology, pathology and all other ‘ologies that acquire and store images as part of the patient record. INFINITT Digital Pathology Solution (IDPS) enables quantitative image analysis and remote reading for primary diagnosis and multi-disciplinary review.  IDPS facilitates collaboration, research and the application of AI. INFINITT’s over-arching mission is to help healthcare providers consolidate systems, streamline workflows, and reduce management complexity to achieve cost benefits while transforming to a more patient-centric healthcare model.



Leica Biosystems (LeicaBiosystems.com) is a cancer diagnostics company and a global leader in workflow solutions. Only Leica Biosystems offers the most comprehensive portfolio that spans the entire workflow from biopsy to diagnosis. With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology. Our experts are committed to delivering Improved Quality, Integrated Solutions, and Optimized Efficiencies leading to breakthrough advances in diagnostic confidence. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Leica Biosystems is headquartered in Germany and operates in over 100 countries.



Mikroscan is committed to partnering with the pathology community by providing technology-enabled products and services which increase pathologists reach, remove barriers to workload efficiency, and enable new discoveries. Our solutions are utilized in hospitals, clinics, universities, and research institutions all over the world. From Frozen Section Support and Assessment of Adequacy of FNAs to Secondary Consultations, our technology serves a variety of robotic microscopy applications in anatomic pathology, veterinary pathology, teaching, and research settings. Mikroscan has ensured location no longer prevents the proper expertise from delivering the proper care. This is distributed pathology; this is the future.



Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The Company builds computational pathology products designed so patients and their care teams can make effective, more informed treatment decisions. With this new class of diagnostic devices positioned to drive the future of pathology, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige’s lightweight platform was purpose-built with pathologists to offer an intuitive user experience, minimize IT burden and costs while ensuring patient safety and data privacy. Paige’s products deliver insights to pathologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first company to receive FDA breakthrough designation for computational pathology products.



PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. Based in Boston, PathAI works with leading life sciences companies and researchers to advance precision medicine. To learn more, visit pathai.com.



The Philips IntelliSite Pathology Solution is a highly scalable product with proven technology that enhances productivity with high-resolution digital images, collaborative features, and case management tools. It is designed to support your clinical practice, improve patient care, and reduce costs across your healthcare system. Complete with an Ultra Fast Scanner, image management system viewer, image management system server and storage software, and a high quality display – pathologists are able to increase their productivity, improve their workflow, and not have to worry about their digital pathology system being as reliable as using a microscope.



The Roche VENTANA product portfolio represents a legacy of innovation and includes automated instruments and reagent systems for slide-based tissue diagnostics for cancer and infectious disease. In addition to fully automated slide staining platforms and specimen workflow software, Roche offers a digital pathology portfolio that includes scanners for whole slide imaging, software to manage the digital workflow, and companion image analysis algorithms. These digital solutions are designed to help AP labs improve workflow efficiency, ensure patient and user safety, and empower precision medicine.  



StageBio--the leading provider of preclinical histology, pathology and archiving services for biopharmaceutical, medical device, and contract research industries.  StageBio’s integrated offering includes efficacy determination, toxicological evaluation for regulatory approval, detailed pathology reporting for GLP studies, image analysis, and immunohistochemistry. We have a reputation for excellence by translating pioneering techniques into information that clients use to further their research. Visit us today at www.StageBio.com






#PathVisions20 Presentations

All content now available to members!


Save the Date for #PathVisions21! 

October 17-19 | Las Vegas, NV


Support Opportunities

PV21 exhibitor prospectus coming soon!